Table 11

Other reported adverse events

Condition

Observations

Treatment


Hypertension

1

UP446 250 mg

Varicose veins

1

UP446 250 mg

Fluid in knee

1

UP446 250 mg

Reduced flexibility

1

Placebo

Psoriasis

2

UP446 250 and 500 mg


Sampalis and Brownell Nutrition Journal 2012 11:21   doi:10.1186/1475-2891-11-21

Open Data